Evidence map›Paper›PMID 41893425›Full record

ArticleVision (Basel, Switzerland)2026

Real-World Comparison of Overall Survival Among Patients With and Without Inherited Retinal Diseases.

Byron L Lam, Carlos E Mendoza-Santiesteban, Dominic Pilon, Dejan Milentijevic, Laura Morrison, Samuel Schwartzbein, Claire Vanden Eynde, Marie-Hélène Lafeuille, Patrick Lefebvre, Ninel Z Gregori

Abstract read
In one paragraph

Article in Vision (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Byron L LamMark J. Daily Inherited Retinal Disease Research Center, Bascom Palmer Eye Institute, Miami Miller School of Medicine, Miami, FL 33136, USA.ORCID 0000-0002-1233-2366
Carlos E Mendoza-SantiestebanMark J. Daily Inherited Retinal Disease Research Center, Bascom Palmer Eye Institute, Miami Miller School of Medicine, Miami, FL 33136, USA.ORCID 0000-0002-6344-4544
Dominic PilonAnalysis Group, Inc., Montréal, QC H3B 0G7, Canada.
Dejan MilentijevicJohnson & Johnson, Titusville, NJ 08560, USA.
Laura MorrisonAnalysis Group, Inc., Montréal, QC H3B 0G7, Canada.
Samuel SchwartzbeinAnalysis Group, Inc., Montréal, QC H3B 0G7, Canada.
Claire Vanden EyndeAnalysis Group, Inc., Montréal, QC H3B 0G7, Canada.
Marie-Hélène LafeuilleAnalysis Group, Inc., Montréal, QC H3B 0G7, Canada.
Patrick LefebvreAnalysis Group, Inc., Montréal, QC H3B 0G7, Canada.
Ninel Z GregoriMark J. Daily Inherited Retinal Disease Research Center, Bascom Palmer Eye Institute, Miami Miller School of Medicine, Miami, FL 33136, USA.

Funding

Johnson & Johnson N/A
6 · The paper itself

Abstract

This study compared real-world overall survival and the risk of physical comorbidities and mental health conditions among patients aged <65 years with versus without inherited retinal diseases (IRDs) in the United States (US). Optum

Indexed as

blindnesselectronic health recordsinherited retinal diseases (IRDs)mental health conditionsmortalityoverall survivalphysical comorbidities

Identifiers

PMID41893425
PMCPMC13030414

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.